1887

Abstract

The study evaluated the in vitro impact of a series of aminophosphinic urease inhibitors on Proteus mirabilis. The group of compounds comprised structurally diverse analogues of diamidophosphate built on an N-C-P scaffold. The influence of urease inhibition on urea-splitting activity was assessed by whole-cell pH-static kinetic measurements. The potential to prevent struvite formation was determined by monitoring changes in pH and ionic composition of artificial urine medium during P. mirabilis growth. The most active compounds exhibited stronger positive effect on urine stability than the acknowledged inhibitor acetohydroxamic acid. The high anti-ureolytic and pH-stabilizing effect of urease inhibitors 4 and 14 was well correlated with their reported kinetic properties against pure urease from P. mirabilis (K i values of 0.62±0.09 and 0.202±0.057 µM, respectively, compared to 5.7±0.4 µM for acetohydroxamic acid). The effect of repressed ureolysis upon the viability of Proteus cells was studied using MTT [3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide] metabolic efficiency assay and LIVE/DEAD fluorescent staining. Most of the compounds caused whole-cell dehydrogenase activity loss; four structures (1, 2, 4 and 14) reduced the culture viability by nearly 70 % at 1 mM concentration. Results of dual fluorescent staining suggested that besides urea-splitting prevention, the structures additionally exerted an outer-membrane-destabilizing effect.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000342
2016-10-18
2019-10-23
Loading full text...

Full text loading...

/deliver/fulltext/jmm/65/10/1123.html?itemId=/content/journal/jmm/10.1099/jmm.0.000342&mimeType=html&fmt=ahah

References

  1. Bailie N. C., Osborne C. A., Leininger J. R., Fletcher T. F., Johnston S. D., Ogburn P. N., Griffith D. P..( 1986;). Teratogenic effect of acetohydroxamic acid in clinically normal beagles. . Am J Vet Res 47: 2604–2611.[PubMed]
    [Google Scholar]
  2. Benini S., Kosikowska P., Cianci M., Mazzei L., Vara A. G., Berlicki Ł., Ciurli S..( 2013;). The crystal structure of Sporosarcina pasteurii urease in a complex with citrate provides new hints for inhibitor design. . J Biol Inorg Chem 18: 391. [CrossRef] [PubMed]
    [Google Scholar]
  3. Benini S., Rypniewski W. R., Wilson K. S., Miletti S., Ciurli S., Mangani S..( 1999;). A new proposal for urease mechanism based on the crystal structures of the native and inhibited enzyme from Bacillus pasteurii: why urea hydrolysis costs two nickels. . Structure 7: 205–216. [CrossRef] [PubMed]
    [Google Scholar]
  4. Benini S., Rypniewski W. R., Wilson K. S., Miletti S., Ciurli S., Mangani S..( 2000;). The complex of Bacillus pasteurii urease with acetohydroxamate anion from X-ray data at 1.55 Å resolution. . J Biol Inorg Chem 5: 110–118. [CrossRef] [PubMed]
    [Google Scholar]
  5. Berlicki L., Bochno M., Grabowiecka A., Białas A., Kosikowska P., Kafarski P..( 2012;). N-substituted aminomethanephosphonic and aminomethane-P-methylphosphinic acids as inhibitors of ureases. . Amino Acids 42: 1937–1945. [CrossRef] [PubMed]
    [Google Scholar]
  6. Boer J. L., Mulrooney S. B., Hausinger R. P..( 2014;). Nickel- dependent metalloenzymes. . Arch Biochem Biophys 544: 142–152. [CrossRef] [PubMed]
    [Google Scholar]
  7. Brooks T., Keevil C. W..( 1997;). A simple artificial urine for the growth of urinary pathogens. . Lett Appl Microbiol 24: 203–206. [CrossRef] [PubMed]
    [Google Scholar]
  8. Chaney A. L., Marbach E. P..( 1962;). Modified reagents for determination of urea and ammonia. . Clin Chem 8: 130–132.[PubMed]
    [Google Scholar]
  9. Chomarat M..( 2000;). Resistance of bacteria in urinary tract infections. . Int J Antimicrob Agents 16: 483–487. [CrossRef] [PubMed]
    [Google Scholar]
  10. Follmer C..( 2010;). Ureases as a target for the treatment of gastric and urinary infections. . J Clin Pathol 63: 424–430. [CrossRef] [PubMed]
    [Google Scholar]
  11. Forlani G..( 1997;). Properties of the 5-enol-pyruvyl-shikimate-3-phosphate synthase isoforms isolated from maize cultured cells. . J Plant Physiol 150: 369–375. [CrossRef]
    [Google Scholar]
  12. Gootz T. D..( 2006;). The forgotten gram-negative bacilli: what genetic determinants are telling us about the spread of antibiotic resistance. . Biochem Pharmacol 71: 1073–1084. [CrossRef] [PubMed]
    [Google Scholar]
  13. Grela E., Ząbek A., Grabowiecka A..( 2015;). Interferences in the optimization of the MTT assay for viability estimation of Proteus mirabilis. . Avicenna J Med Biotechnol 7: 159–167.[PubMed]
    [Google Scholar]
  14. Griffith D. P., Gleeson M. J., Lee H., Longuet R., Deman E., Earle N..( 1991;). Randomized, double-blind trial of Lithostat (acetohydroxamic acid) in the palliative treatment of infection-induced urinary calculi. . Eur Urol 20: 243–247.[PubMed]
    [Google Scholar]
  15. Konieczna I., Zarnowiec P., Kwinkowski M., Kolesinska B., Fraczyk J., Kaminski Z., Kaca W..( 2012;). Bacterial urease and its role in long-lasting human diseases. . Curr Protein Pept Sci 13: 789–806. [CrossRef] [PubMed]
    [Google Scholar]
  16. Kosikowska P., Berlicki Ł..( 2011;). Urease inhibitors as potential drugs for gastric and urinary tract infections: a patent review. . Expert Opin Ther Pat 21: 945–957. [CrossRef] [PubMed]
    [Google Scholar]
  17. Lee C. H., Lee Y. T., Kung C. H., Ku W. W., Kuo S. C., Chen T. L., Fung C. P..( 2015;). Risk factors of community-onset urinary tract infections caused by plasmid-mediated AmpC β-lactamase-producing Enterobacteriaceae. . J Microbiol Immunol Infect 48: 269–275. [CrossRef] [PubMed]
    [Google Scholar]
  18. Macegoniuk K., Dziełak A., Mucha A., Berlicki Ł..( 2015;). Bis(aminomethyl)phosphinic acid, a highly promising scaffold for the development of bacterial urease inhibitors. . ACS Med Chem Lett 6: 146–150. [CrossRef] [PubMed]
    [Google Scholar]
  19. Marmion C. J., Griffith D., Nolan K. B..( 2004;). Hydroxamic acids – an intriguing family of enzyme inhibitors and biomedical ligands. . Eur J Inorg Chem 15: 3003.[CrossRef]
    [Google Scholar]
  20. Mucha A., Kafarski P., Berlicki Ł..( 2011;). Remarkable potential of the α-aminophosphonate/phosphinate structural motif in medicinal chemistry. . J Med Chem 54: 5955. [CrossRef] [PubMed]
    [Google Scholar]
  21. Muri E. M., Nieto M. J., Sindelar R. D., Williamson J. S..( 2002;). Hydroxamic acids as pharmacological agents. . Curr Med Chem 9: 1631–1653. [CrossRef] [PubMed]
    [Google Scholar]
  22. Oleksyszyn J..( 2000;). Aminophosphonic and aminophosphinic acid derivatives in the design of transition state analogue inhibitors: biomedical opportunities and limitations. . In Aminophosphonic and Aminophosphinic Acids , pp. 537–557. Edited by Kukhar V. P., Hudson H. R.. Chichester:: John Wiley & Sons;.
    [Google Scholar]
  23. Prywer J., Torzewska A., Płociński T..( 2012;). Unique surface and internal structure of struvite crystals formed by Proteus mirabilis. . Urol Res 40: 699–707. [CrossRef] [PubMed]
    [Google Scholar]
  24. Rice L. B..( 2006;). Unmet medical needs in antibacterial therapy. . Biochem Pharmacol 71: 991–995. [CrossRef] [PubMed]
    [Google Scholar]
  25. Stickler D. J..( 2014;). Clinical complications of urinary catheters caused by crystalline biofilms: something needs to be done. . J Intern Med 276: 120–129. [CrossRef] [PubMed]
    [Google Scholar]
  26. Vassiliou S., Grabowiecka A., Kosikowska P., Berlicki Ł..( 2012;). Three component Kabachnik-Fields condensation leading to substituted aminomethane-P-hydroxymethylphosphonic acids as a tool for screening of bacterial urease inhibitors. . ARKIVOC 4: 33–43.
    [Google Scholar]
  27. Vassiliou S., Grabowiecka A., Kosikowska P., Yiotakis A., Kafarski P., Berlicki Ł..( 2008;). Design, synthesis, and evaluation of novel organophosphorus inhibitors of bacterial ureases. . J Med Chem 51: 5736–5744. [CrossRef] [PubMed]
    [Google Scholar]
  28. Vassiliou S., Kosikowska P., Grabowiecka A., Yiotakis A., Kafarski P., Berlicki Ł..( 2010;). Computer-aided optimization of phosphinic inhibitors of bacterial ureases. . J Med Chem 53: 5597–5606. [CrossRef] [PubMed]
    [Google Scholar]
  29. Zhanel G. G., Hisanaga T. L., Laing N. M., DeCorby M. R., Nichol K. A., Palatnik L. P., Johnson J., Noreddin A., Harding G. K. et al.( 2005;). Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). . Int J Antimicrob Agents 26: 380–388. [CrossRef] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000342
Loading
/content/journal/jmm/10.1099/jmm.0.000342
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error